MilliporeSigma, a life science leader, is a business of Merck KGaA, Darmstadt, Germany, providing services as a strategic partner to help advance the promise of life saving therapies. With the acquisition of Sigma-Aldrich (SAFC), we now have the largest offering of products and contract manufacturing services for formulations, actives and biotechnology processes. Our joint ADC offering now includes a full range of services that spans conjugation, mAbs, linkers and payloads, process development, and much more
Piramal Healthcare’s Antibody Drug Conjugate Business is one of the world’s leading contract development and manufacturing teams delivering early phase clinical and late phase commercial supplies. Our flexible manufacturing regime and dedication to ADC processing is why our clients choose Piramal Healthcare as their preferred partner. We seek to reduce the complexity associated with ADC processing allowing for integrated and seamless scale-up of each unique ADC program.
SCIEX offers an innovative set of LC, MS, CE, software, and compliance and validation solutions to meet the demands of modern therapeutic discovery and development. From accurate DAR measurement and comprehensive characterization to streamlined biotransformation solution to integrated Qual/Quant and low-level quantitation of antibody drug conjugates (ADC), SCIEX provides innovative solutions to simplify your analyses and accelerate your ADC program.
MabPlex International provides one-stop, high-quality CRO/CMO solutions for biologics (mAb and ADCs) to our global clients. We are dedicated to help our clients accelerate development process and reduce manufacture costs. MabPlex has extensive experiences in manufacturing for therapeutic antibodies and antibody-drug conjugates (ADCs). Our manufacturing facilities with large-scale disposable lines and world-class instruments are operated by well-trained professionals in full compliance with U.S, European, and Chinese GMP regulations.
Mersana is advancing its own pipeline of next-generation drugs with best-in-class potential to address unmet needs and improve patient outcomes in multiple oncology indications. Utilizing our technology, we are developing a portfolio of next-generation antibody-drug conjugates (ADC) with superior properties not found with current ADC technologies.
NewBio Therapeutics (NewBio) is an innovative company focusing on the discovery of proprietary site-specific conjugation technology, toxins and antibody-drug conjugates (ADCs) for cancer treatment. Our site-specific linkers lead to the preparation of more homogeneous ADC products with controlled DAR values of four, three, or two, which bear improved in-vivo stability, lower toxicity, and enhanced anti-cancer activities. While building up our own ADC pipelines, we are also seeking worldwide collaborations with other corporations.
Novasep is a leading provider of integrated manufacturing solutions for the Life Science industries offering a wide range of flexible assets, specialized technologies and advanced process capabilities for the synthesis and purification of APIs and HPAPIs. We provide unique services for the development and cGMP manufacture of antibody-drug conjugates including the payload, the linker and the monoclonal antibody.
Sartorius-Stedim Biotech is a key supplier of Bioprocessing technologies and Biomanufacturing related services.
Benefit from the most comprehensive bioprocess and single-use technology portfolio coupled with our process engineering expertise, ensuring a robust process development and manufacturing approach… Read more
Waters Corporation creates business advantages for laboratory-dependent organizations by delivering scientific innovation to enable customers to make significant advancements. Waters helps customers make profound discoveries, optimize laboratory operations, deliver product performance, and ensure regulatory compliance with a connected portfolio of separations and analytical science, laboratory informatics, mass spectrometry, as well as thermal analysis.
The VarioSys® was developed by Bausch+Stroebel and SKAN to meet the modular and flexible needs for the biotech and ADC industry. In the same suite for potent products you can perform both aseptic compounding and aseptically fill a wide variety of containers (e.g. vials, syringes, cartridges plus more). Our filling technologies fit inside the SKAN isolator for processing and our clients are filling both clinical supplies and commercial products for launch on the same line. Find out more.